CDK inhibitor Palbociclib, Purity ≥98%

Synonym: 571190-30-2; PD0332991; PD-0332991; PD 0332991; CDK inhibitor

Product Size

10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Palbociclib is an CDK kinase inhibitor that disrupts cell division processes. It targets Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D2, and DYRK1A.

Molecular Weight

447.53

Molecular Formula

C₂₄H₂₉N₇O₂

Targets

Cdk4/cyclin D1: 11 nM; Cdk4/cyclin D3: 9 nM; Cdk6/cyclin D2: 16 nM; DYRK1A: 2000 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

Palbociclib (PD 0332991) can be used to study the selective inhibition of CDK4/6 in cancer therapy.